A Study Looking at the Safety and Levels of PF-06952229 in the Body
A Study Looking at the Safety and Levels of PF-06952229 in the Body. A Phase 1 Dose Escalation and Expansion Study Evaluating Safety, Tolerability and Pharmacokinetics of PF-06952229 in Adult Patients With Advanced Solid Tumors.
Category & Conditions: Cancer
Medicine: PF-06952229
ClinicalTrials.gov Identifier (NCT): NCT03685591
Protocol ID: C3881001
PrintDownloadOpen Plain Language Summary Result: Click here